Use of Novel Second-Line Targeted Therapies in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Use of Novel Second-Line Targeted Therapies in Non–Small Cell Lung Cancer

Published:2006-02 Issue: Volume:33 Page:9-16
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Massarelli Erminia,Herbst Roy S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference54 articles.

1. Randomized phase III trial of pemetrexed versus docetaxel in patients with non–small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

2. National Comprehensive Cancer Network: Practice guidelines in oncology. Available at: http://www.nccn.org/physician_gls/f_guidelines.html (accessed July 6, 2005)

3. American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline;Pfister;J Clin Oncol,2004

4. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small-cell lung cancer (the IDEAL 1 trial);Fukuoka;J Clin Oncol,2003

5. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non–small cell lung cancer;Kris;JAMA,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells;Pharmacology;2019-10-18

2. Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine;Scientific Reports;2017-11-08

3. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2016-03-30

4. Understanding Oral Chemotherapy Prescribing Patterns at the End of Life at a Comprehensive Cancer Center: Analysis of a Massachusetts Payer Claims Database;Journal of Oncology Practice;2015-09

5. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway;Tumor Biology;2014-12-27